Pharmacy benefit managers ... 2025 Future of Healthcategory US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression January 28, 2025 Healthcare ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Several of the biggest US pharmacy benefit managers have generated more than $7.3bn in revenue by charging ...
Revenue came to $39 billion for the fiscal quarter ended in November, driven by higher prices for branded drugs and prescription volumes at the company’s US retail pharmacy division, the company ...